Acadia Healthcare Company, Inc. (NASDAQ:ACHC) Receives Consensus Rating of “Hold” from Analysts

Shares of Acadia Healthcare Company, Inc. (NASDAQ:ACHC) have been given an average rating of “Hold” by the fifteen research firms that are covering the firm, Marketbeat Ratings reports. Two analysts have rated the stock with a sell recommendation, five have given a hold recommendation, seven have assigned a buy recommendation and one has given a strong buy recommendation to the company. The average 1-year price objective among analysts that have covered the stock in the last year is $26.8462.

Several analysts recently commented on the stock. Zacks Research upgraded shares of Acadia Healthcare from a “strong sell” rating to a “hold” rating in a research report on Thursday, March 5th. Barclays upped their price target on shares of Acadia Healthcare from $20.00 to $25.00 and gave the company an “equal weight” rating in a research report on Thursday, April 30th. Cantor Fitzgerald upped their price target on shares of Acadia Healthcare from $20.00 to $30.00 and gave the company a “neutral” rating in a research report on Friday, May 1st. KeyCorp reaffirmed an “overweight” rating and set a $30.00 price target on shares of Acadia Healthcare in a research note on Wednesday, May 27th. Finally, Royal Bank Of Canada upped their price target on shares of Acadia Healthcare from $28.00 to $31.00 and gave the stock an “outperform” rating in a research note on Monday, May 4th.

Acadia Healthcare Stock Up 0.7%

Shares of NASDAQ:ACHC opened at $25.50 on Friday. The company has a market capitalization of $2.35 billion, a PE ratio of -2.08, a P/E/G ratio of 8.44 and a beta of 0.69. The company has a current ratio of 1.71, a quick ratio of 1.71 and a debt-to-equity ratio of 1.27. Acadia Healthcare has a twelve month low of $11.43 and a twelve month high of $30.20. The firm has a 50 day simple moving average of $25.45 and a 200-day simple moving average of $19.87.

Acadia Healthcare (NASDAQ:ACHC) last issued its quarterly earnings data on Wednesday, April 29th. The company reported $0.37 earnings per share for the quarter, topping the consensus estimate of $0.28 by $0.09. The business had revenue of $828.80 million during the quarter, compared to the consensus estimate of $823.51 million. Acadia Healthcare had a negative net margin of 32.84% and a positive return on equity of 7.09%. The company’s revenue was up 7.6% compared to the same quarter last year. During the same quarter in the previous year, the firm earned $0.40 EPS. Acadia Healthcare has set its Q2 2026 guidance at 0.300-0.400 EPS. On average, equities analysts predict that Acadia Healthcare will post 1.5 EPS for the current fiscal year.

Hedge Funds Weigh In On Acadia Healthcare

Institutional investors and hedge funds have recently made changes to their positions in the stock. EverSource Wealth Advisors LLC grew its stake in shares of Acadia Healthcare by 54.8% during the 2nd quarter. EverSource Wealth Advisors LLC now owns 1,404 shares of the company’s stock worth $32,000 after purchasing an additional 497 shares during the period. Hantz Financial Services Inc. grew its stake in shares of Acadia Healthcare by 501.9% during the 3rd quarter. Hantz Financial Services Inc. now owns 2,185 shares of the company’s stock worth $54,000 after purchasing an additional 1,822 shares during the period. Wells Fargo & Company MN grew its stake in shares of Acadia Healthcare by 208.9% during the 4th quarter. Wells Fargo & Company MN now owns 2,233 shares of the company’s stock worth $32,000 after purchasing an additional 1,510 shares during the period. Bayforest Capital Ltd acquired a new position in shares of Acadia Healthcare during the 4th quarter worth $52,000. Finally, GAMMA Investing LLC grew its stake in shares of Acadia Healthcare by 124.7% during the 4th quarter. GAMMA Investing LLC now owns 4,862 shares of the company’s stock worth $69,000 after purchasing an additional 2,698 shares during the period.

Acadia Healthcare Company Profile

Acadia Healthcare Company, Inc (NASDAQ: ACHC) is a publicly traded provider of behavioral healthcare services headquartered in Franklin, Tennessee. Founded in 2005, the company has grown through organic expansion and strategic acquisitions to establish itself as a leading specialist in mental health and addiction treatment across the United States.

Acadia operates a diversified network of inpatient psychiatric hospitals, residential treatment centers, outpatient clinics and intensive outpatient programs.